![](https://www.diabetesnews.com/wp-content/uploads/2014/03/FDA_publicdomain2_6-150x150.jpg)
The U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar(TM) (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes.
Read more